Metastases comprised of either Krt19- or Tgm2-edited PDA cells lacked the CXCL12–KRT19 coating and had greater numbers of CD3+ T cells (SI Appendix, Fig. S13 A and B). This evidence concerns the gene CXCL12 and Patent ductus arteriosus.